Favorable research funding sceanrio, increase in the demand for next-generation sequencing technique in cancer profiling and use of biomarkers in cancer profiling are driving the demand of the market.
A report on Cancer Tumor Profiling market is published by Emergen Research, offering current developments and emerging trends of the market. The report offers a comprehensive overview of the market along with details about market size, market share, revenue growth, and top companies.
This market’s growth is attributed to the increasing use of biomarkers in cancer profiling, eventually rising adoption of proteomic methods for biomarker research, thus helping to increase the drug development process over the estimated period. The growing demand for personalized medicine and the rise in cancer incidence across the globe is augmenting the demand for the industry. According to the World Health Organization (WHO), Lung and Breast cancer is a common type of cancer, with around 2.09 million cases every year. The growing demand for cancer tumor profiling is driving the market for the estimated period.
Get Free Sample Report@ https://www.emergenresearch.com/request-sample/50
The primary aim of the report is to offer market overview, product scope, growth prospects, and risks. The report also offers in depth information about each player in the global Cancer Tumor Profiling market along with its global standing, financial status, product launch, business expansion plans among others. The market players are focused on developing various strategies such as partnerships, mergers and acquisitions, joint ventures, product launches, and research and development investments.
Companies profiled in the global Cancer Tumor Profiling market:
Caris Life Sciences, Foundation Medicine, GenomeDX, Genomic Health, Guardant Health, Helomics Corporation, HTG Molecular Diagnostics, Inc., Nanostring Technologies, Neogenomics Inc., Oxford Gene Technology, Qiagen N.V., Ribomed Biotechnologies Inc., among others..
Further Key Highlights
- The Genomics segment was valued at 2.76 Billion in 2019, owing to the rise in the research institutes’ funding for developing modified medicine is expected to increase the demand for the genomics industry. The use of genomics technology by various companies for cancer tumor profiling is anticipated to increase the overall genomics industry’s demand for the upcoming forecast period.
- Asia Pacific countries such as China, India, and Japan, have seen a striking increase in cancer tumor profiling. Developing economies, including India, Singapore, and Korea, are anticipated to intensify global demand.
Detailed Regional Analysis covers:
· North America (U.S., Canada)
· Europe (U.K., Italy, Germany, France, Rest of EU)
· Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
· Latin America (Chile, Brazil, Argentina, Rest of Latin America)
· Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Get discount on report@ https://www.emergenresearch.com/request-discount/50
Emergen Research have segmented the Cancer Tumor Profiling Market on the basis of technique type, technology, application, and region:
- Technique Type Outlook (Revenue, USD Billion; 2017-2027)
- Genomics
- Epigenetics
- Metabolomics
- Proteomics
- Technology Outlook (Revenue, USD Billion; 2017-2027)
- Immunoassays
- In Situ Hybridization
- Fluorescence In Situ Hybridization (FISH)
- Chromogenic In Situ Hybridization (CISH)
- Microarray
- Polymerase Chain Reaction (PCR)
- Sequencing Technologies
- Next Generation Sequencing(NGS)
- Pyro Sequencing
- Sanger Sequencing
- Other Technologies
- Application Outlook (Revenue, USD Billion; 2017-2027)
- Research Application
- Biomarker Discovery
- Personalized Cancer Medicine
- Clinical Application
- Oncological Diagnostics
- Prognostics
- Monitoring and Treatment
- Screening
Key Features of the Cancer Tumor Profiling Market Report:
· The report offers details about key drivers, restraints, opportunities, challenges, growth prospects, limitations, and threats
· The report encompasses details about the key companies, product portfolio along with specifications, production valuation, and market shares
· Evaluation of key current and emerging market trends and growth prospects
· It also offers research-backed estimations for the forecast period of eight years, primarily to estimate the potential market growth
· Brief overview of industry with regards to research and development, technological advancements, and product development
· In-depth assessment of upstream raw materials, downstream buyers, demands, and current market scenario
Proceed to buy@ https://www.emergenresearch.com/select-license/50
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Cancer Tumor Profiling Market Segmentation & Impact Analysis
4.1. Cancer Tumor Profiling Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increase in the demand for next-generation sequencing technique in cancer profiling
4.2.2.2. Increase in the use of biomarkers in cancer profiling
4.2.2.3. Rise in incidence of cancer across the globe
4.2.2.4. Rise in the adoption of the cancer profiling methods by oncologists
4.2.3. Market restraints analysis
4.2.3.1. High capital investment
4.2.3.2. Technical issues with sample collection and storage
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Cancer Tumor Profiling Market By Technique Type Insights & Trends, Revenue (USD Million)
5.1. Technique Type Dynamics & Market Share, 2019 & 2027
5.1.1. Genomics
5.1.2. Epigenetics
5.1.3. Metabolomics
5.1.4. Proteomics
Continued…!
Enquire for customization in Report @: https://www.emergenresearch.com/request-for-customization/50
Thank you for reading our report. The report can be customized as per requirement. Please get in touch with us for further inquiry and we will ensure you get the report best suited for your needs.
Explore Similar Reports offered by Emergen Research:
Femtech Market@ https://www.emergenresearch.com/industry-report/femtech-market
Microfluidics Market@ https://www.emergenresearch.com/industry-report/microfluidics-market
GERD Drugs and Devices Market@ https://www.emergenresearch.com/industry-report/gerd-drugs-and-devices-market
Cell Culture Market@ https://www.emergenresearch.com/industry-report/cell-culture-market
Interoperability Solutions in Healthcare Market@ https://www.emergenresearch.com/industry-report/interoperability-solutions-in-healthcare-market
Global Non-Invasive Prenatal Testing Market@ https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
